Article: Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt–Jakob disease: evaluation of a first-in-human treatment programme Post published:March 28, 2022 Post category:News / Research TLN_April2022_p342_354 (pdf) The Lancet Neurology April2022 p342_354 (online) from The Lancet Neurology You Might Also Like Link to post: ION717 trial fully enrolled January 6, 2025 Link to Prion Alliance blog: ‘All of the things’ June 12, 2025 Link to article: Brainwide silencing of prion protein by AAV-mediated delivery of an engineered compact epigenetic editor June 29, 2024
Link to article: Brainwide silencing of prion protein by AAV-mediated delivery of an engineered compact epigenetic editor June 29, 2024
